{"title":"Dog Duchenne muscular dystrophy characterization","authors":"Jorge Ferreira","doi":"10.1038/s41684-025-01595-4","DOIUrl":null,"url":null,"abstract":"<p>Duchenne muscular dystrophy (DMD) is a severe, inherited muscle-wasting disorder caused by mutations in the <i>DMD</i> gene, leading to dystrophin deficiency and downstream pathological cascades, including calcium overload, muscle necrosis, fibrosis, and progressive cardiac and skeletal muscle dysfunction. While mouse models are commonly used, they fail to fully model the human disease. The canine DMD model offers a more accurate representation of the disease, exhibiting progressive muscle weakness, respiratory decline, and cardiomyopathy. In a study in <i>Disease Models & Mechanisms</i>, researchers addressed an important technical limitation by developing a custom antibody specific to canine Dwarf open reading frame (DWORF), a micropeptide implicated in calcium handling and muscle function. Using this tool, they found that DWORF expression—previously demonstrated to have a protective role in muscular wasting diseases—is reduced in the skeletal and cardiac muscles of adult DMD dogs. This is the first characterization of DWORF protein in a large-animal model of DMD, providing groundwork for preclinical evaluation of DWORF-targeted therapies in a system that more accurately reflects human DMD pathology.</p><p><b>Original reference:</b> Gibson, A.M. et al. <i>Dis. Model & Mech</i>. <b>18</b>, dmm052285 (2025)</p>","PeriodicalId":17936,"journal":{"name":"Lab Animal","volume":"26 1","pages":""},"PeriodicalIF":3.9000,"publicationDate":"2025-07-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Lab Animal","FirstCategoryId":"97","ListUrlMain":"https://doi.org/10.1038/s41684-025-01595-4","RegionNum":3,"RegionCategory":"农林科学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"VETERINARY SCIENCES","Score":null,"Total":0}
引用次数: 0
Abstract
Duchenne muscular dystrophy (DMD) is a severe, inherited muscle-wasting disorder caused by mutations in the DMD gene, leading to dystrophin deficiency and downstream pathological cascades, including calcium overload, muscle necrosis, fibrosis, and progressive cardiac and skeletal muscle dysfunction. While mouse models are commonly used, they fail to fully model the human disease. The canine DMD model offers a more accurate representation of the disease, exhibiting progressive muscle weakness, respiratory decline, and cardiomyopathy. In a study in Disease Models & Mechanisms, researchers addressed an important technical limitation by developing a custom antibody specific to canine Dwarf open reading frame (DWORF), a micropeptide implicated in calcium handling and muscle function. Using this tool, they found that DWORF expression—previously demonstrated to have a protective role in muscular wasting diseases—is reduced in the skeletal and cardiac muscles of adult DMD dogs. This is the first characterization of DWORF protein in a large-animal model of DMD, providing groundwork for preclinical evaluation of DWORF-targeted therapies in a system that more accurately reflects human DMD pathology.
Original reference: Gibson, A.M. et al. Dis. Model & Mech. 18, dmm052285 (2025)
期刊介绍:
LabAnimal is a Nature Research journal dedicated to in vivo science and technology that improves our basic understanding and use of model organisms of human health and disease. In addition to basic research, methods and technologies, LabAnimal also covers important news, business and regulatory matters that impact the development and application of model organisms for preclinical research.
LabAnimal's focus is on innovative in vivo methods, research and technology covering a wide range of model organisms. Our broad scope ensures that the work we publish reaches the widest possible audience. LabAnimal provides a rigorous and fair peer review of manuscripts, high standards for copyediting and production, and efficient publication.